CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. Analyst Price Targets

Wall Street analyst price targets and consensus rating for CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. (CERO).

Price Target Range — 2 Quarters

Analyst Consensus — 2 Analysts

2Hold

# Analysts2

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 18, 2025	D. Boral Capital	Jason Kolbert	Downgrade	Buy→Hold	—
Nov 3, 2025	Maxim Group	Jason McCarthy	Downgrade	Buy→Hold	—
Oct 30, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$30
Oct 22, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$30
Oct 13, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$30
Sep 23, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$30
Sep 9, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$30
Sep 5, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$30
Aug 4, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$30
Jun 24, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$30
Jun 23, 2025	D. Boral Capital	Jason Kolbert	Upgrade	Hold→Buy	$30
May 30, 2025	D. Boral Capital	Jason Kolbert	Downgrade	Buy→Hold	—
May 19, 2025	Maxim Group	Jason McCarthy	Initiate	Buy	$60
Apr 25, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$220
Apr 23, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$220
Apr 22, 2025	D. Boral Capital	Jason Kolbert	Initiate	Buy	$220

Analyst Ratings News

PRO
Maxim Group Downgrades CERo Therapeutics Hldgs to Hold

Maxim Group analyst Jason McCarthy downgrades CERo Therapeutics Hldgs (NASDAQ:CERO) from Buy to Hold.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price target.

Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price target.

Benzinga Newsdesk

CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc.

뉴스

파트너 / 기고자

벤징가 글로벌

CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Maxim Group Downgrades CERo Therapeutics Hldgs to Hold

PRO
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

PRO
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

PRO
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

PRO
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

PRO
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc.

뉴스

파트너 / 기고자

벤징가 글로벌

CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROMaxim Group Downgrades CERo Therapeutics Hldgs to Hold

PROD. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

PROD. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

PROD. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

PROD. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

PROD. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

PRO
Maxim Group Downgrades CERo Therapeutics Hldgs to Hold

PRO
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

PRO
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

PRO
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

PRO
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

PRO
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target